Literature DB >> 20424362

Short-term case fatality rate and associated factors among inpatients with diabetic ketoacidosis and hyperglycemic hyperosmolar state: a hospital-based analysis over a 15-year period.

Hua-Fen Chen1, Chih-Yuan Wang, Hsin-Yu Lee, Ting-Ting See, Mei-Hsiu Chen, Ju-Ying Jiang, Ming-Tsang Lee, Chung-Yi Li.   

Abstract

BACKGROUND AND
PURPOSE: Diabetic ketoacidosis (DKA) and hyperglycemic hyperosmolar state (HHS) are usually life threatening, but the recent trend of 28-day case-fatality and associated risk factors including Charlson index have not been known. Our aim was to evaluate the 28-day case-fatality rate among hospitalized DKA and HHS patients in a teaching hospital in Taiwan from 1991 to 2005.
METHODS: DKA and HHS admissions, identified from in-patient electronic database, were linked to Taiwan's national death registry. Kaplan-Meier analysis was used to determine the 28-day case-fatality rates of DKA and HHS, and to compare the trend of case-fatality over three consecutive 5-year periods (i.e, 1991-1995, 1996-2000, 2001-2005). We also used the Cox proportional hazard regression model to explore the determinants of 28-day case-fatality of the study patients.
RESULTS: The 28-day case-fatality rates for DKA and HHS were 6.10% and 18.83%, and the lowest ones were observed in 2001-2005 (2.65% and 11.63% in DKA and HHS, respectively). Pneumonia was a significant predictor for increased 28-day case-fatality in both illnesses. Additionally, older age and stroke were significantly associated with increased case-fatality in DKA patients while myocardial infarction and higher Charlson index were significant predictors for higher case-fatality in HHS patients.
CONCLUSION: Improvements in case-fatality in recent years for both DKA and HHS were found in the study hospital. Further reduction of the case-fatality rate among DKA and HHS patients can be achieved by optimal management of certain co-morbidities.

Entities:  

Mesh:

Year:  2010        PMID: 20424362     DOI: 10.2169/internalmedicine.49.2965

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  8 in total

1.  Cases: "safety" technology: a hidden cause of diabetic ketoacidosis.

Authors:  Catherine H Y Yu
Journal:  CMAJ       Date:  2012-02-27       Impact factor: 8.262

2.  The Study of Different Clinical Pattern of Diabetic Ketoacidosis and Common Precipitating Events and Independent Mortality Factors.

Authors:  M G Mahesh; Rajendra Prasad Shivaswamy; Bj Subhash Chandra; Sajid Syed
Journal:  J Clin Diagn Res       Date:  2017-04-01

Review 3.  Respiratory failure in diabetic ketoacidosis.

Authors:  Nikifor K Konstantinov; Mark Rohrscheib; Emmanuel I Agaba; Richard I Dorin; Glen H Murata; Antonios H Tzamaloukas
Journal:  World J Diabetes       Date:  2015-07-25

Review 4.  Adult hyperglycemic crisis: a review and perspective.

Authors:  Devin W Steenkamp; Sara M Alexanian; Marie E McDonnell
Journal:  Curr Diab Rep       Date:  2013-02       Impact factor: 4.810

5.  Variation in use of intensive care for adults with diabetic ketoacidosis*.

Authors:  Hayley B Gershengorn; Theodore J Iwashyna; Colin R Cooke; Damon C Scales; Jeremy M Kahn; Hannah Wunsch
Journal:  Crit Care Med       Date:  2012-07       Impact factor: 7.598

6.  Characteristics of hyperglycemic crises in an adult population in a teaching hospital in Colombia.

Authors:  Carlos Esteban Builes-Montaño; Andres Chavarriaga; Lina Ballesteros; Manuela Muñoz; Sofia Medina; Jorge Hernando Donado-Gomez; Alex Ramirez-Rincón
Journal:  J Diabetes Metab Disord       Date:  2018-09-19

7.  Temporal trend in hospitalizations for acute diabetic complications: a nationwide study, Italy, 2001-2010.

Authors:  Flavia Lombardo; Marina Maggini; Gabriella Gruden; Graziella Bruno
Journal:  PLoS One       Date:  2013-05-23       Impact factor: 3.240

8.  Corrected sodium levels for hyperglycemia is a better predictor than measured sodium levels for clinical outcomes among patients with extreme hyperglycemia.

Authors:  Chien Chuang; Ya-Wun Guo; Harn-Shen Chen
Journal:  J Chin Med Assoc       Date:  2020-09       Impact factor: 3.396

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.